Gentle warming of 1,1‘-bis(dimethylgallyl)ferrocene ( 1 ) leads to the formation of trimethylgallium and the thermolabile compound [{Fe(η 5 -C 5 H 4 ) 2 } 2 {GaMe} 2 ] ( 2 ), a [1.1]ferrocenophane featuring group 13 elements in bridging positions. While NMR data for 2 prove a dynamic structure in solution, X-ray data reveal an anti conformation of the ferrocenophane framework in the solid state. The anti conformation is maintained in the thermolabile adducts 2a − g, which are obtained from 2 and the donors diethyl ether ( 2a ), pyridine ( 2b ), pyrimidine ( 2c ), quinoxaline ( 2d ), DMSO ( 2e ), pyrazine ( 2f ), and dioxane ( 2g ), by donor-exchange reactions ( 2b − g ) or on gentle warming of the respective donor adducts of 1 . Rodlike polymers are formed either by interaction of 2 with bidentate donors ( 2f, g ) or by π-stacking effects of aromatic molecules acting as monodentate donors ( 2b − d ). Steric requirements inhibit the complex formation between 2 and the donor phenazine. A cyclic voltammogram of 2b in pyridine reveals two reversible oxidation steps at −314 and −114 mV, indicating only weak electron delocalization in the cationic species. The formation of 2 from 1 has been shown to be reversible and thus is an example of an application of “dynamic covalent chemistry” as synthetic strategy.
No takes yet. Share an insight, caveat, or question.
Althoff et al. (2003) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: